In summary, delivery of binding AS25 into K562 cells resulted in selective inhibition of BCR::ABL1 signaling and led to induction of apoptosis in CML cells. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.